January 11, 2023
FPMAJ Chairman Sunao Manabe The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) will be calling for the reexamination of the current deflationary drug price revision method towards the FY2024 reimbursement reform. To this end, it will work to have...read more